Lazard Asset Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Sell |
512,135
-45,659
| -8% | -$1.48M | 0.02% | 442 |
|
|
2025
Q1 | $21.1M | Buy |
557,794
+71,030
| +15% | +$2.68M | 0.03% | 338 |
|
|
2024
Q4 | $39.8M | Buy |
+486,764
| New | +$39.8M | 0.06% | 229 |
|
|
2023
Q3 | – | Sell |
-9,268
| Closed | -$461K | – | 2431 |
|
|
2023
Q2 | $461K | Buy |
+9,268
| New | +$461K | ﹤0.01% | 1143 |
|
|
2023
Q1 | – | Sell |
-7,741
| Closed | -$371K | – | 2488 |
|
|
2022
Q4 | $371K | Buy |
+7,741
| New | +$371K | ﹤0.01% | 1176 |
|